Sandoz announces that the European Commission has granted marketing authorization for Wyost and Jubbonti, the first and only biosimilar versions of Amgen s Xgeva and Prolia in Europe.Both products.
In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price.
Amgen s Xgeva cleared in US for rare bone cancer complication pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.